A bioabsorbable, implantable device made of synthetic materials (e.g., ceramics such as tricalcium phosphate or hydroxyapatite) combined with animal-derived bone growth factors (e.g., bovine collagen) intended to replace bone lost through trauma, surgery, or p
| Company | Devices | Share |
|---|---|---|
| Berkeley Advanced Biomaterials, Llc | 101 | 33% |
| Stryker Corporation | 34 | 11% |
| Seaspine Orthopedics Corporation | 34 | 11% |
| Curasan Ag | 29 | 9% |
| Novabone Products, Llc | 28 | 9% |
| Isotis Orthobiologics, Inc. | 26 | 8% |
| Dsm Biomedical, Inc. | 25 | 8% |
| Xtant Medical Holdings, Inc. | 15 | 5% |
| Nuvasive, Inc. | 7 | 2% |
| Orthofix Us Llc | 5 | 2% |
| Revisios B.V. | 3 | 1% |
| Kuros Biosciences B.V. | 1 | 0% |
Company = labeler of record on GUDID. 12 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| MQV | Filler, Bone Void, Calcium Compound | 233 |
| MQV | FILLER, BONE VOID, CALCIUM COMPOUND | 135 |
| OIS | Calcium Salt Bone Void Filler, Drillable, Non-Screw Augmenta | 10 |
| LYC | Bone grafting material, synthetic | 4 |
Use these as the dimensions to specify in a tender line.
308 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Orthopaedic bone void filling material, synthetic/animal-derived", from 12 companies. The largest labeler is Berkeley Advanced Biomaterials, Llc with 33% of records.
MQV (Filler, Bone Void, Calcium Compound), MQV (FILLER, BONE VOID, CALCIUM COMPOUND), OIS (Calcium Salt Bone Void Filler, Drillable, Non-Screw Augmenta), LYC (Bone grafting material, synthetic)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add orthopaedic bone void filling material, synthetic/animal-derived to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.